Latest IMGN reports update at 2023-11-02: 2023-Q32022-Q42022-Q3
ImmunoGen logo
ImmunoGen IMGN
$ 31.23 0.0%

ImmunoGen Balance Sheet 2011-2024 | IMGN

Annual Balance Sheet ImmunoGen

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-260 M -460 M - -149 M -260 M -265 M -145 M -278 M -142 M -195 M -161 M -191 M

Long Term Debt

11.1 M 15.2 M - 2.08 M 2.06 M 2.05 M 100 M - - - - -

Long Term Debt Current

4.1 M 3.54 M 3.15 M 2.97 M - - - - - - - -

Total Non Current Liabilities

- - - 234 M 214 M 257 M 308 M 243 M 68.4 M 72.6 M 80.2 M 63.1 M

Total Current Liabilities

122 M 101 M 122 M 77.4 M 70.7 M 55.8 M 55.8 M 35.8 M 21.3 M 19.2 M 16.3 M -

Total Liabilities

193 M 200 M 266 M 311 M 284 M 313 M 369 M 279 M 89.6 M 91.7 M 96.4 M 77.7 M

Deferred Revenue

13.9 M 44.4 M 29.2 M 309 K 317 K 1.4 M 13.6 M 333 K 2.37 M 1.49 M 3.33 M 3.32 M

Retained Earnings

-1.69 B -1.47 B -1.33 B -1.29 B -1.18 B -1.03 B -854 M -709 M -648 M -577 M -504 M -431 M

Total Assets

349 M 526 M 355 M 235 M 295 M 295 M 287 M 314 M 165 M 214 M 180 M 218 M

Cash and Cash Equivalents

275 M 479 M 294 M 176 M 262 M 267 M 160 M 245 M 142 M 195 M 161 M 191 M

Book Value

156 M 326 M 89.6 M -76.1 M 11 M -17.9 M -82.3 M 35.1 M 75.7 M 122 M 83.9 M 140 M

Total Shareholders Equity

156 M 326 M 89.6 M -76.1 M 11 M -17.9 M -153 M 35.1 M 75.7 M 122 M 83.9 M 140 M

All numbers in USD currency

Quarterly Balance Sheet ImmunoGen

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

7.76 M 8.92 M 10 M 11.1 M 12.2 M - 14.3 M 15.2 M 16 M 17 M 17.9 M 18.7 M 18.7 M 2.08 M 2.08 M 2.08 M 2.08 M 2.08 M 2.08 M 2.06 M 2.06 M 2.06 M 2.06 M 2.05 M 2.05 M 2.05 M 2.05 M 97 M 97 M 97 M 96.6 M - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

261 M 223 M 166 M 193 M 181 M - 175 M 200 M 220 M 233 M 252 M 266 M 266 M 266 M 266 M 311 M 311 M 311 M 311 M 284 M 284 M 284 M 284 M 313 M 313 M 313 M 313 M 352 M 352 M 352 M 362 M 268 M 274 M 273 M 279 M 51.1 M 84.1 M 89.6 M 89.6 M 72.5 M 80.6 M 91.7 M 91.7 M 94.8 M 95.4 M 96.4 M 96.4 M 92.9 M 75.3 M 77.7 M 77.7 M

Deferred Revenue

37.2 M 14.4 M 13.4 M 13.9 M 15.1 M - 23.4 M 44.4 M 53.5 M 53.8 M 51.5 M 29.2 M 29.2 M 29.2 M 29.2 M 309 K 309 K 309 K 309 K 317 K 317 K 317 K 317 K 1.4 M 27.1 M 26.2 M 1.81 M 14.5 M 14.5 M 14.5 M 13.6 M 1.54 M 858 K 333 K 333 K 1.11 M 23.7 M 2.37 M 2.37 M 2.52 M 2.26 M 1.49 M 1.49 M 1.3 M 1.38 M 2.35 M 2.35 M 3.39 M 3.85 M 2.35 M 2.35 M

Retained Earnings

-1.71 B -1.74 B -1.74 B -1.69 B -1.64 B - -1.5 B -1.47 B -1.43 B -1.4 B -1.37 B -1.33 B -1.33 B -1.33 B -1.33 B -1.29 B -1.29 B -1.29 B -1.29 B -1.18 B -1.18 B -1.18 B -1.18 B -1.03 B -1.03 B -1.03 B -1.03 B -933 M -933 M -933 M -854 M -776 M -743 M -709 M -709 M -657 M -670 M -648 M -648 M -584 M -588 M -577 M -577 M -554 M -529 M -504 M -504 M -463 M -450 M -431 M -431 M

Total Assets

822 M 714 M 288 M 349 M 359 M - 482 M 526 M 297 M 301 M 346 M 355 M 355 M 355 M 355 M 235 M 235 M 235 M 235 M 295 M 295 M 295 M 295 M 295 M 295 M 295 M 295 M 199 M 199 M 199 M 279 M 252 M 286 M 308 M 314 M 129 M 143 M 165 M 165 M 203 M 200 M 214 M 214 M 231 M 253 M 180 M 180 M 208 M 199 M 218 M 218 M

Cash and Cash Equivalents

606 M 572 M 201 M 275 M 310 M 374 M 438 M 479 M 246 M 240 M 283 M 294 M 294 M 294 M 294 M 176 M 176 M 176 M 176 M 262 M 262 M 262 M 262 M 267 M 267 M 267 M 267 M 160 M 160 M 160 M 196 M 212 M 248 M 212 M 248 M 107 M 122 M 107 M 122 M 178 M 175 M 178 M 175 M 211 M 234 M 211 M 234 M 168 M 180 M 168 M 180 M

Book Value

562 M 491 M 122 M 156 M 178 M - 306 M 326 M 77.1 M 68.5 M 94.1 M 89.6 M 89.6 M 89.6 M 89.6 M -76.1 M -76.1 M -76.1 M -76.1 M 11 M 11 M 11 M 11 M -17.9 M -17.9 M -17.9 M -17.9 M -153 M -153 M -153 M -82.3 M -16.7 M 11.6 M 35.1 M 35.1 M 77.5 M 59 M 75.7 M 75.7 M 130 M 119 M 122 M 122 M 136 M 157 M 83.9 M 83.9 M 115 M 124 M 140 M 140 M

Total Shareholders Equity

562 M 491 M 122 M 156 M 178 M 250 M 306 M 326 M 77.1 M 68.5 M 94.1 M 89.6 M 89.6 M 89.6 M 89.6 M -76.1 M -76.1 M -76.1 M -76.1 M 11 M 11 M 11 M 11 M -17.9 M -17.9 M -17.9 M -17.9 M -153 M -153 M -153 M -82.3 M -16.7 M 11.6 M 35.1 M 35.1 M 77.5 M 59 M 75.7 M 75.7 M 130 M 119 M 122 M 122 M 136 M 157 M 83.9 M 83.9 M 115 M 124 M 140 M 140 M

All numbers in USD currency